Development consulting and affairs group PharmaLex has expanded its operations to Italy, opening a new office in Milan.
Acting as a base for PharmaLex Italy, the new location will be headed by regulatory affairs specialist Fulvia Feltrin, who will work to build the company’s local presence and establish a new legal entity.
She said: “I care about delivering high quality services in the fastest and most efficient way, and I like to operate in an environment where people work with passion, commitment and enthusiasm.
“With the establishment of the new Italian office, we will be able to offer clients a complete, high-standard service portfolio, promoting a wide range of services, and, for multinational businesses, extended market coverage.”
The group’s chief executive officer Dr Thomas Dobmeyer, said the establishment of the new office is an ‘important milestone’ in PharmaLex’s European progress, adding that Italy is the third largest European pharmaceutical market after Germany and France.
He added: “What Italian customers need, are high standard services in line with all EU regulations and requirements, plus a local presence to work in strict collaboration establishing strong sense of partnership.”
The new office adds to the group’s already-established 31 offices in 16 countries comprising of over 700 employees.